Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Patti

Showing results (11-20 of 376) with videos related to

Pageof 38
Sort By:
Functional Neurology|March 11, 2011
Psychometric properties of the Italian version of the Guy's Neurological Disability ScaleAngelo Pappalardo, Francesco Patti
Expert Opinion on Drug Metabolism & Toxicology|June 26, 2013
The pharmacokinetics of glatiramer acetate for multiple sclerosis treatmentSilvia Messina, Francesco Patti
Autoimmune Diseases|May 7, 2011
Lights and shadows of cyclophosphamide in the treatment of multiple sclerosisFrancesco Patti, Salvatore Lo Fermo
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 3, 2014
Measuring the cost of cognitive-motor dual tasking during walking in multiple sclerosisCarmela Leone, Francesco Patti, Peter Feys
Functional Neurology|March 31, 2016
Disability may influence patient willingness to participate in decision making on first-line therapy in multiple sclerosisEmanuele D'Amico, Carmela Leone, Francesco Patti
International Journal of Molecular Sciences|February 25, 2016
Offspring Number Does Not Influence Reaching the Disability's Milestones in Multiple Sclerosis: A Seven-Year Follow-Up StudyEmanuele D'Amico, Carmela Leone, Francesco Patti
Expert Review of Neurotherapeutics|January 24, 2020
Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatmentAurora Zanghì, Emanuele D'Amico, Francesco Patti
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 19, 2010
Treatment options of cognitive impairment in multiple sclerosisFrancesco Patti, Carmela Leone, Emanuele D'Amico
BMC Neurology|December 9, 2015
Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case reportFrancesco Patti, Carmela Leone, Mario Zappia
Expert Opinion on Pharmacotherapy|December 1, 2016
Can new chemical therapies improve the management of multiple sclerosis in children?Emanuele D'Amico, Aurora Zanghì, Francesco Patti
Pageof 38

Showing results (11-20 of 376) with videos related to

Sort By:
Pageof 38
Functional Neurology|March 11, 2011
Psychometric properties of the Italian version of the Guy's Neurological Disability ScaleAngelo Pappalardo, Francesco Patti
Expert Opinion on Drug Metabolism & Toxicology|June 26, 2013
The pharmacokinetics of glatiramer acetate for multiple sclerosis treatmentSilvia Messina, Francesco Patti
Autoimmune Diseases|May 7, 2011
Lights and shadows of cyclophosphamide in the treatment of multiple sclerosisFrancesco Patti, Salvatore Lo Fermo
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 3, 2014
Measuring the cost of cognitive-motor dual tasking during walking in multiple sclerosisCarmela Leone, Francesco Patti, Peter Feys
Functional Neurology|March 31, 2016
Disability may influence patient willingness to participate in decision making on first-line therapy in multiple sclerosisEmanuele D'Amico, Carmela Leone, Francesco Patti
International Journal of Molecular Sciences|February 25, 2016
Offspring Number Does Not Influence Reaching the Disability's Milestones in Multiple Sclerosis: A Seven-Year Follow-Up StudyEmanuele D'Amico, Carmela Leone, Francesco Patti
Expert Review of Neurotherapeutics|January 24, 2020
Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatmentAurora Zanghì, Emanuele D'Amico, Francesco Patti
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 19, 2010
Treatment options of cognitive impairment in multiple sclerosisFrancesco Patti, Carmela Leone, Emanuele D'Amico
BMC Neurology|December 9, 2015
Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case reportFrancesco Patti, Carmela Leone, Mario Zappia
Expert Opinion on Pharmacotherapy|December 1, 2016
Can new chemical therapies improve the management of multiple sclerosis in children?Emanuele D'Amico, Aurora Zanghì, Francesco Patti
Pageof 38